Jump to main content
Jump to site search

Issue 72, 2017
Previous Article Next Article

Cav2.2 and Cav3.1 calcium channel inhibitors from Valeriana jatamansi Jones

Author affiliations

Abstract

In China, the roots and rhizomes of Valeriana jatamansi Jones are traditionally used to treat gastrointestinal and rheumatic pain. Small molecule inhibitors of N-type (Cav2.2) and T-type (Cav3.1–3.3) calcium channels have become attractive resources in analgesic drug development. Therefore, in the present study, the isolated compounds (1–13) from V. jatamansi, including three new valepotriates (1–3), were initially evaluated on Cav2.2 and Cav3.1. As a result, compounds 1–12 showed weak to potent inhibition on Cav2.2 peak currents at 30 μM. Among them, compounds 1, 6, 7, 11 and 12 exhibited significant antagonistic effects, with EC50 values of 4.33, 2.18, 1.13, 2.70 and 7.8 μM, respectively. Meanwhile, the aforementioned compounds exhibited 18.2 ± 2.5% to 49.2 ± 7.1% peak current inhibition on Cav3.1 at 30 μM. In addition, they also exhibited noticeable specificity against Cav1.2, Cav2.1, and KCNH2 (hERG) channels.

Graphical abstract: Cav2.2 and Cav3.1 calcium channel inhibitors from Valeriana jatamansi Jones

Back to tab navigation

Supplementary files

Publication details

The article was received on 03 Jul 2017, accepted on 21 Sep 2017 and first published on 26 Sep 2017


Article type: Paper
DOI: 10.1039/C7RA07327E
RSC Adv., 2017,7, 45878-45884
  • Open access: Creative Commons BY license
  •   Request permissions

    Cav2.2 and Cav3.1 calcium channel inhibitors from Valeriana jatamansi Jones

    H. Jiang, F. Dong, J. Zhou, J. Hu, J. Yang and Y. Nian, RSC Adv., 2017, 7, 45878
    DOI: 10.1039/C7RA07327E

    This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. Material from this article can be used in other publications provided that the correct acknowledgement is given with the reproduced material.

    Reproduced material should be attributed as follows:

    • For reproduction of material from NJC:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the Centre National de la Recherche Scientifique (CNRS) and the RSC.
    • For reproduction of material from PCCP:
      [Original citation] - Published by the PCCP Owner Societies.
    • For reproduction of material from PPS:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the European Society for Photobiology, the European Photochemistry Association, and RSC.
    • For reproduction of material from all other RSC journals:
      [Original citation] - Published by The Royal Society of Chemistry.

    Information about reproducing material from RSC articles with different licences is available on our Permission Requests page.

Search articles by author

Spotlight

Advertisements